Discontinued — last reported Q3 '25
Equity Method Investments
West Pharmaceutical Services Equity Method Investments decreased by 1.5% to $209.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.3%, from $211.90M to $209.20M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows relatively stable performance with a -0.2% CAGR.
Analysis
How to read this metric
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
Detailed definition
These are investments in entities where the company exercises significant influence but does not have full control. The...
Peer comparison
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investmentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.60M | $8.60M | $207.70M | $10.10M | $10.10M | $11.40M | $204.90M | $7.90M | $9.20M | $5.70M | $210.00M | $6.60M | $7.20M | $217.50M | $202.10M | $211.90M | $224.70M | $220.90M | $212.30M | $209.20M |
| QoQ Change | — | +0.0% | >999% | -95.1% | +0.0% | +12.9% | >999% | -96.1% | +16.5% | -38.0% | >999% | -96.9% | +9.1% | >999% | -7.1% | +4.8% | +6.0% | -1.7% | -3.9% | -1.5% |
| YoY Change | — | — | — | — | +17.4% | +32.6% | -1.3% | -21.8% | -8.9% | -50.0% | +2.5% | -16.5% | -21.7% | >999% | -3.8% | >999% | >999% | +1.6% | +5.0% | -1.3% |
Equity Method Investments at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's equity method investments?
- West Pharmaceutical Services (WST) reported equity method investments of $209.20M in Q1 2026.
- How has West Pharmaceutical Services's equity method investments changed year-over-year?
- West Pharmaceutical Services's equity method investments decreased by 1.3% year-over-year, from $211.90M to $209.20M.
- What is the long-term trend for West Pharmaceutical Services's equity method investments?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's equity method investments has grown at a -0.2% compound annual growth rate (CAGR), from $214.70M to $212.30M.
- What does equity method investments mean?
- The value of investments in other companies where the firm has significant influence but not total control.